Lipfendra: Merck’s First-of-Its-Kind Cholesterol Pill Could End Statins as We Know Them – A Heart Health Revolution
The FDA approved Merck's Lipfendra, a potent oral PCSK9 inhibitor, on July 16. This once-daily pill dramatically reduces LDL cholesterol by 60-70% when combined with...
